Richard Band

Richard Band

Richard Band is the author of Contrary Investing, in addition to numerous investment monographs. He has appeared on financial radio and TV and has been quoted in The Wall Street Journal, Business Week, Forbes and other leading publications. Richard graduated from Yale University, magna cum laude, and has been a respected investment commentator since 1982.

Recent Articles

Toronto-Dominion Bank (TD) Stock: The Great White North’s Bank of Choice

TD continues to expand in the U.S., which has helped diversify its revenue stream while also hedging its revenue growth.

The Coca-Cola Co (KO) Stock Is Fizzing With Value

WIth The Coca-Cola Co (KO) proving its ability to flourish, now is the perfect time to buy some KO stock -- while the Street is still cautious.

Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve

The Big Pharma is set to have a very good 2017 and put 2016 behind it.

Why AbbVie Inc (ABBV) Stock Is Still a Long-Term Winner

The market has been hot and cold on biotechs, but AbbVie stock is a great long-term winner. Here's what you need to know about ABBV.

Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma

Sanofi has a rough time during 2016, but after the U.S. presidential election and with several forward-looking decisions, SNY stock is a buy.

McDonald’s Corporation (MCD) Stock Is Back on the “Buy” Track

McDonald's (MCD) has weathered a difficult 2016. Now, though, fresh ideas are flowing once more than should get MCD stock back on its feet.

Apple Inc. (AAPL) Stock Is Still the Envy of the Market

Apple Inc. (AAPL) is still the hippest hardware company in the world, and AAPL stock is well positioned moving into the New Year.

Can Apple Inc. (AAPL) Stock Sustain This Relief Rally?

Apple Inc. may not be a massive growth story anymore, but AAPL stock still offers a lot as a value investment.

Metlife Inc (MET) Is Starting Its Run

Investors are hoping MET stock will get a boost following the election of Donald Trump.

Procter & Gamble Co (PG) Offers Growth AND Stability

Procter & Gamble has started its new fiscal year with a bang, reaffirming PG stock as a stellar long-term hold.